Transmission of SARS-CoV-2 among recruits in a US Army training environment: a brief report.
COVID-19
nonpharmaceutical interventions
public health
Journal
Journal of public health (Oxford, England)
ISSN: 1741-3850
Titre abrégé: J Public Health (Oxf)
Pays: England
ID NLM: 101188638
Informations de publication
Date de publication:
28 08 2023
28 08 2023
Historique:
received:
14
12
2022
revised:
10
02
2023
medline:
1
9
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
In 2020, preventive measures were implemented to mitigate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among 600-700 recruits arriving weekly at a basic combat training (BCT) facility in the southern United States. Trainees were sorted into companies and platoons (cocoons) at arrival, tested, quarantined for 14 days with daily temperature and respiratory-symptom monitoring and retested before release into larger groups for training where symptomatic testing was conducted. Nonpharmaceutical measures, such as masking, and social distancing, were maintained throughout quarantine and BCT. We assessed for SARS-CoV-2 transmission in the quarantine milieu. Nasopharyngeal (NP) swabs were collected at arrival and at the end of quarantine and blood specimens at both timepoints and at the end of BCT. Epidemiological characteristics were analyzed for transmission clusters identified from whole-genome sequencing of NP samples. Among 1403 trainees enrolled from 25 August to 7 October 2020, epidemiological analysis identified three transmission clusters (n = 20 SARS-CoV-2 genomes) during quarantine, which spanned five different cocoons. However, SARS-CoV-2 incidence decreased from 2.7% during quarantine to 1.5% at the end of BCT; prevalence at arrival was 3.3%. These findings suggest layered SARS-CoV-2 mitigation measures implemented during quarantine minimized the risk of further transmission in BCT.
Sections du résumé
BACKGROUND
In 2020, preventive measures were implemented to mitigate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among 600-700 recruits arriving weekly at a basic combat training (BCT) facility in the southern United States. Trainees were sorted into companies and platoons (cocoons) at arrival, tested, quarantined for 14 days with daily temperature and respiratory-symptom monitoring and retested before release into larger groups for training where symptomatic testing was conducted. Nonpharmaceutical measures, such as masking, and social distancing, were maintained throughout quarantine and BCT. We assessed for SARS-CoV-2 transmission in the quarantine milieu.
METHODS
Nasopharyngeal (NP) swabs were collected at arrival and at the end of quarantine and blood specimens at both timepoints and at the end of BCT. Epidemiological characteristics were analyzed for transmission clusters identified from whole-genome sequencing of NP samples.
RESULTS
Among 1403 trainees enrolled from 25 August to 7 October 2020, epidemiological analysis identified three transmission clusters (n = 20 SARS-CoV-2 genomes) during quarantine, which spanned five different cocoons. However, SARS-CoV-2 incidence decreased from 2.7% during quarantine to 1.5% at the end of BCT; prevalence at arrival was 3.3%.
CONCLUSIONS
These findings suggest layered SARS-CoV-2 mitigation measures implemented during quarantine minimized the risk of further transmission in BCT.
Identifiants
pubmed: 37132356
pii: 7147866
doi: 10.1093/pubmed/fdad026
pmc: PMC10470341
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
748-752Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Influenza Other Respir Viruses. 2015 Nov;9(6):308-314
pubmed: 26271648
N Engl J Med. 2020 Dec 17;383(25):2407-2416
pubmed: 33176093
Epidemiology. 2022 Nov 1;33(6):797-807
pubmed: 35944149
J Adolesc Health. 2021 Jan;68(1):28-34
pubmed: 33153883
J Clin Microbiol. 2021 Apr 20;59(5):
pubmed: 33653700
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):88-94
pubmed: 33476314
Clin Infect Dis. 2000 Sep;31(3):663-70
pubmed: 11017812
Open Forum Infect Dis. 2021 Jul 29;8(9):ofab407
pubmed: 34514020
Epidemics. 2023 Jun;43:100691
pubmed: 37267710
J Clin Pathol. 2021 Apr;74(4):207-208
pubmed: 32631944
Clin Infect Dis. 2014 Oct;59(7):962-8
pubmed: 24991024
Wellcome Open Res. 2020 May 1;5:83
pubmed: 32656368